While eradicating new‐onset Pseudomonas aeruginosa in children with cystic fibrosis is an important issue, there is no clear evidence about the best treatment approach. This retrospective observational cohort study aims… Click to show full abstract
While eradicating new‐onset Pseudomonas aeruginosa in children with cystic fibrosis is an important issue, there is no clear evidence about the best treatment approach. This retrospective observational cohort study aims to compare the effectiveness of intravenous therapy versus inhalation with/without oral therapy in the eradication of new‐onset P. aeruginosa, determine the factors affecting the treatment success and assess lung function at baseline and posttreatment.
               
Click one of the above tabs to view related content.